Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Journal of clinical oncology

Results: 26-50/4838

Authors: Kuerer, HM Hunt, KK Singletary, SE Ames, FC
Citation: Hm. Kuerer et al., Unusual aspects of breast cancer - Case 3. Blue hives during lymphatic mapping for breast cancer, J CL ONCOL, 19(9), 2001, pp. 2573-2574

Authors: Baile, WF Beale, EA
Citation: Wf. Baile et Ea. Beale, Giving bad news to cancer patients: Matching process and content, J CL ONCOL, 19(9), 2001, pp. 2575-2577

Authors: Copur, MS Ledakis, P Bolton, M Norvell, M Muhvic, J
Citation: Ms. Copur et al., Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?, J CL ONCOL, 19(9), 2001, pp. 2578-2578

Authors: Panasci, LC
Citation: Lc. Panasci, Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?, J CL ONCOL, 19(9), 2001, pp. 2578-2578

Authors: Bagley, CM Rowbotham, RK
Citation: Cm. Bagley et Rk. Rowbotham, Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?, J CL ONCOL, 19(9), 2001, pp. 2578-2579

Authors: Tonkin, K
Citation: K. Tonkin, Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?, J CL ONCOL, 19(9), 2001, pp. 2579-2580

Authors: Costa, SD Kaufmann, M
Citation: Sd. Costa et M. Kaufmann, Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?, J CL ONCOL, 19(9), 2001, pp. 2580-2580

Authors: Nabholtz, JM Bonneterre, J Buzdar, A Robertson, JFR Thurlimann, B Steinberg, M Webster, A von Euler, M
Citation: Jm. Nabholtz et al., Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer? Reply, J CL ONCOL, 19(9), 2001, pp. 2580-2582

Authors: Soiffer
Citation: Soiffer, CD6+ donor marrow T-cell depletion as the sole form of graft-versus-disease prophylaxis in patients undergoing allogeneic bone marrow transplant fromunrelated donors (vol 19, pg 1152, 2001), J CL ONCOL, 19(9), 2001, pp. 2583-2583

Authors: Voogd, AC
Citation: Ac. Voogd, Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials (vol 19, pg 1688, 2001), J CL ONCOL, 19(9), 2001, pp. 2583-2583

Authors: Dorr
Citation: Dorr, Phase I/II study of the P-glycoprotein modulator PSC 833 in patients with acute myeloid leukemia (vol 19, pg 1589, 2001), J CL ONCOL, 19(9), 2001, pp. 2583-2583

Authors: Bilchik
Citation: Bilchik, Molecular staging of early colon cancer on the basis of sentinel node analysis: A multicenter phase II trial (vol 19, pg 1128, 2001), J CL ONCOL, 19(9), 2001, pp. 2583-2583

Authors: Sharma, S
Citation: S. Sharma, Development of inhalational agents for oncologic use (vol 19, pg 1839, 2001), J CL ONCOL, 19(9), 2001, pp. 2583-2583

Authors: Kornblith, AB
Citation: Ab. Kornblith, Does palliative care palliate?, J CL ONCOL, 19(8), 2001, pp. 2111-2113

Authors: Schiller, JH Adak, S Cella, D DeVore, RF Johnson, DH
Citation: Jh. Schiller et al., Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593 - A phase III trial of the Eastern Cooperative Oncology Group, J CL ONCOL, 19(8), 2001, pp. 2114-2122

Authors: Langendijk, JA Aaronson, NK de Jong, JMA ten Velde, GPM Muller, MJ Lamers, RJ Slotman, BJ Wouters, EFM
Citation: Ja. Langendijk et al., Prospective study on quality of life before and after radical radiotherapyin non-small-cell lung cancer, J CL ONCOL, 19(8), 2001, pp. 2123-2133

Authors: Witherspoon, RP Deeg, HJ Storer, B Anasetti, C Storb, R Appelbaum, FR
Citation: Rp. Witherspoon et al., Hematopoietic stern-cell transplantation for treatment-related leukemia ormyelodysplasia, J CL ONCOL, 19(8), 2001, pp. 2134-2141

Authors: Gandhi, V Plunkett, W Weller, S Du, M Ayres, M Rodriguez, CO Ramakrishna, P Rosner, GL Hodge, JP O'Brien, S Keating, MJ
Citation: V. Gandhi et al., Evaluation of the combination of nelarabine and fludarabine in leukemias: Clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells, J CL ONCOL, 19(8), 2001, pp. 2142-2152

Authors: Byrd, JC Murphy, T Howard, RS Lucas, MS Goodrich, A Park, K Pearson, M Waselenko, JK Ling, G Grever, MR Grillo-Lopez, AJ Rosenberg, J Kunkel, L Flinn, IW
Citation: Jc. Byrd et al., Rituximab using a thrice weekly dosing schedule in B-Cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity, J CL ONCOL, 19(8), 2001, pp. 2153-2164

Authors: O'Brien, SM Kantarjian, H Thomas, DA Giles, FJ Freireich, EJ Cortes, J Lerner, S Keating, MJ
Citation: Sm. O'Brien et al., Rituximab dose-escalation trial in chronic lymphocytic leukemia, J CL ONCOL, 19(8), 2001, pp. 2165-2170

Authors: Ratner, L Lee, J Tang, SH Redden, D Hamzeh, F Herndier, B Scadden, D Kaplan, L Ambinder, R Levine, A Harrington, W Grochow, L Flexner, C Tan, B Straus, D
Citation: L. Ratner et al., Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy, J CL ONCOL, 19(8), 2001, pp. 2171-2178

Authors: Mraz-Gernhard, S Natkunam, Y Hoppe, RT LeBoit, P Kohler, S Kim, YH
Citation: S. Mraz-gernhard et al., Natural killer/natural killer-like T-Cell lymphoma, CD56+, presenting in the skin: An increasingly recognized entity with an aggressive course, J CL ONCOL, 19(8), 2001, pp. 2179-2188

Authors: Andrews, DW Resnicoff, M Flanders, AE Kenyon, L Curtis, M Merli, G Baserga, R Iliakis, G Aiken, RD
Citation: Dw. Andrews et al., Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas, J CL ONCOL, 19(8), 2001, pp. 2189-2200

Authors: Sonis, ST Oster, G Fuchs, H Bellm, L Bradford, WZ Edelsberg, J Hayden, V Eilers, J Epstein, JB LeVeque, FG Miller, C Peterson, DE Schubert, MM Spijkervet, FKL Horowitz, M
Citation: St. Sonis et al., Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation, J CL ONCOL, 19(8), 2001, pp. 2201-2205

Authors: Oliver, JW Kravitz, RL Kaplan, SH Meyers, FJ
Citation: Jw. Oliver et al., Individualized patient education and coaching to improve pain control among cancer outpatients, J CL ONCOL, 19(8), 2001, pp. 2206-2212
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>